All In MedTech

FDA Clearance Tracker · P990026-S021

GLUCOWATCH G2 BIOGRAPHER

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 25, 2004 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 25, 2004

Approved

Time to decision

147 days

Received Oct 1, 2003. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P990026-S021
Device name
GLUCOWATCH G2 BIOGRAPHER
Applicant
Animas Corp.
Applicant location
West Chester, PA
Received
Oct 1, 2003
Decided
Feb 25, 2004
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P990026

Device type

Device class
Class III

Every decision under product code NCT

FDA's approval statement

As written in FDA's record.

APPROVAL FOR AN EXPANSION OF THE LABELING TO INCLUDE A DESCRIPTION OF PRE-TREATMENT PRODUCTS AND A METHOD TO MINIMIZE THE AFFECTS OF SKIN IRRITATION WITHOUT AFFECTING THE ACCURACY OF G2 BIOGRAPHER GLUCOSE MEASUREMENTS.

Source documents

Other decisions for Animas Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.